MX2022012841A - Sistema de entrega transdérmica y/o tópica que comprende hidroxicloroquina y/o cloroquina. - Google Patents

Sistema de entrega transdérmica y/o tópica que comprende hidroxicloroquina y/o cloroquina.

Info

Publication number
MX2022012841A
MX2022012841A MX2022012841A MX2022012841A MX2022012841A MX 2022012841 A MX2022012841 A MX 2022012841A MX 2022012841 A MX2022012841 A MX 2022012841A MX 2022012841 A MX2022012841 A MX 2022012841A MX 2022012841 A MX2022012841 A MX 2022012841A
Authority
MX
Mexico
Prior art keywords
day
hydroxychloroquine
chloroquine
delivery system
transdermal
Prior art date
Application number
MX2022012841A
Other languages
English (en)
Inventor
Nisarg Modi
Fotios M Plakogiannis
Original Assignee
Glanis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glanis Pharmaceuticals Inc filed Critical Glanis Pharmaceuticals Inc
Publication of MX2022012841A publication Critical patent/MX2022012841A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un sistema transdérmico de administración de fármacos (TDDS) del tipo reservorio o emplasto o adhesivo para administrar hidroxicloroquina y/o cloroquina para el tratamiento de artritis reumatoide, lupus eritematoso, SARS CoV-2, porfiria cutánea tardía para aplicación continua durante 1 día, 2 días, 3 días, 4 días, 5 días, 6 días y/o 7 días.
MX2022012841A 2020-04-14 2021-04-13 Sistema de entrega transdérmica y/o tópica que comprende hidroxicloroquina y/o cloroquina. MX2022012841A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063009718P 2020-04-14 2020-04-14
PCT/US2021/027051 WO2021211558A1 (en) 2020-04-14 2021-04-13 Transdermal and/or topical delivery system comprising hydroxychloroquine and/or chloroquine

Publications (1)

Publication Number Publication Date
MX2022012841A true MX2022012841A (es) 2022-12-02

Family

ID=78084997

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012841A MX2022012841A (es) 2020-04-14 2021-04-13 Sistema de entrega transdérmica y/o tópica que comprende hidroxicloroquina y/o cloroquina.

Country Status (8)

Country Link
US (1) US20230123388A1 (es)
EP (1) EP4135673A4 (es)
JP (1) JP2023521563A (es)
CN (1) CN115397402A (es)
AU (1) AU2021256454A1 (es)
CA (1) CA3175771A1 (es)
MX (1) MX2022012841A (es)
WO (1) WO2021211558A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023520845A (ja) * 2020-04-20 2023-05-22 グラニス ファーマシューティカル インコーポレイテッド ヒドロキシクロロキン及び／又はクロロキンを含む経口送達システム

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5314894A (en) * 1992-09-15 1994-05-24 Sterling Winthrop Inc. (S)-(+)-hydroxychloroquine
AU778475B2 (en) * 1999-12-16 2004-12-09 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US20060078604A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
JP5542791B2 (ja) * 2009-02-18 2014-07-09 久光製薬株式会社 経皮吸収製剤
ES2829386T3 (es) * 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
CA2927146A1 (en) * 2012-07-03 2014-01-09 Graceland Biotechnology Inc. Compositions and methods for treating and inhibiting viral infections
CN104352495A (zh) * 2014-11-15 2015-02-18 广州凯普生物科技有限公司 一种治疗疣类疾病的药物
US9770448B1 (en) * 2016-06-30 2017-09-26 Justice E. OBI Compositions and methods for treatment of Bowen's disease and related diseases
WO2018022817A1 (en) * 2016-07-27 2018-02-01 Corium International, Inc. Donepezil transdermal delivery system
CN109288816B (zh) * 2018-12-04 2019-11-22 广州凯普医药科技有限公司 一种氯喹凝胶及其制备方法和应用

Also Published As

Publication number Publication date
US20230123388A1 (en) 2023-04-20
EP4135673A4 (en) 2024-05-08
EP4135673A1 (en) 2023-02-22
AU2021256454A1 (en) 2022-09-29
CA3175771A1 (en) 2021-10-21
CN115397402A (zh) 2022-11-25
JP2023521563A (ja) 2023-05-25
WO2021211558A1 (en) 2021-10-21

Similar Documents

Publication Publication Date Title
MX2022012938A (es) Sistema de entrega oral que comprende hidroxicloroquina y/o cloroquina.
CY1108362T1 (el) Διαταξη παροχης φαρμακου που ειναι ευδιακριτη με τις ακτινες χ
SA520420004B1 (ar) جهاز توصيل دواء بعنصر مُستشعر
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
MX2022012841A (es) Sistema de entrega transdérmica y/o tópica que comprende hidroxicloroquina y/o cloroquina.
BRPI0511611A (pt) configuração de dispositivo médico baseada em reconhecimento de informação de identificação
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
MX2020011371A (es) Nuevos dispositivos medicos, vehiculos de suministro y fabricacion de los mismos.
EP4354455A3 (en) Techniques and devices providing adaptivity and personalization in diabetes treatment
ME00578A (en) Use of gastrointestinal lipase inhibitors
BR0207738A (pt) Sistema terapêutico transdermal altamente flex–vel com nicotina como subst ncia ativa
MX2023003448A (es) Composicion farmaceutica que comprende conjugado de anticuerpo-farmaco y uso de la misma.
MX2023013840A (es) Derivado de piperazina y uso del mismo en medicina.
ZA202006415B (en) Tetrabenazine transdermal delivery device
MX2023015286A (es) Conjugado ligando-farmaco y uso de este.
CL2022000683A1 (es) Uso de derivado de glutarimida para superar la resistencia a esteroides y tratar enfermedades relacionadas con la señalización aberrante del interferón gamma. (divisional de solicitud 202101316)
GB202000254D0 (en) An efficient drug delivery device based on the respiratory medicine department
PH12019500137A1 (en) Vaginal composition comprising a combination of estrogen and vitamin d
TWD220257S (zh) 醫療用流體輸送裝置
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
EP4241822A4 (en) MEDICAL DELIVERY DEVICE AND DRUG DELIVERY SYSTEM
MX2020013385A (es) Metodos para modular los niveles de plasma de metabolitos de tetrabenazina utilizando bupropion.
EP4061346A4 (en) COMBINATION THERAPY BASED ON CANNABIDIOL AND/OR COBICISTAT
MX2022012262A (es) Fitoecdisonas y derivados de estas para su uso en el tratamiento de insuficiencia de la funcion respiratoria durante una infeccion viral.
BR0015531A (pt) Tratamento de lúpus eritematoso sistêmico (sle) com desidroepiandrosterona